Verus Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Sell
7,335
-147
-2% -$34.2K 0.12% 115
2025
Q4
$1.55M Buy
7,482
+245
+3% +$48.4K 0.1% 132
2025
Q3
$1.34M Buy
7,237
+719
+11% +$123K 0.1% 129
2025
Q2
$996K Buy
6,518
+244
+4% +$37.5K 0.09% 137
2025
Q1
$1.04M Sell
6,274
-238
-4% -$37.2K 0.1% 129
2024
Q4
$942K Sell
6,512
-152
-2% -$23.6K 0.09% 135
2024
Q3
$1.08M Buy
6,664
+455
+7% +$72.5K 0.11% 123
2024
Q2
$908K Buy
6,209
+516
+9% +$76.7K 0.09% 133
2024
Q1
$901K Sell
5,693
-214
-4% -$34.1K 0.1% 127
2023
Q4
$926K Sell
5,907
-339
-5% -$52K 0.11% 114
2023
Q3
$973K Buy
6,246
+286
+5% +$47.2K 0.14% 101
2023
Q2
$986K Sell
5,960
-690
-10% -$111K 0.14% 100
2023
Q1
$1.03M Sell
6,650
-1,303
-16% -$210K 0.16% 95
2022
Q4
$1.4M Sell
7,953
-548
-6% -$94.6K 0.26% 62
2022
Q3
$1.39M Sell
8,501
-38
-0.4% -$6.43K 0.26% 59
2022
Q2
$1.51M Sell
8,539
-992
-10% -$177K 0.3% 58
2022
Q1
$1.68M Buy
+9,531
New +$1.62M 0.26% 65
2020
Q1
$568K Buy
4,329
+547
+14% +$77.6K 0.18% 78
2019
Q4
$552K Buy
+3,782
New +$513K 0.18% 95

Other funds holding JNJ

Verus Capital Partners's JNJ Position: Q1 2026 in Review

Verus Capital Partners reduced its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, selling an estimated $34.2K and leaving 7,335 shares worth $1.79M. The position accounts for 0.12% of the portfolio, ranked #115.

Verus Capital Partners first reported a position in JNJ in Q4 2019 and has held it in 19 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Verus Capital Partners held 7,335 shares of Johnson & Johnson worth $1.79M as of Q1 2026.
  • Verus Capital Partners sold 147 Johnson & Johnson shares in Q1 2026, an estimated $34.2K.
  • Johnson & Johnson made up 0.12% of Verus Capital Partners's portfolio in Q1 2026, its #115 holding.
  • Verus Capital Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 19 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.